In people without diabetes (normal blood sugar), Vildagliptin does not stimulate insulin secretion or cause a decrease in glucose levels
These effects were generally mild to moderate in intensity and were most frequent during the dose escalation period, becoming less common as participants remained on their maintenance dose
The Evidence: While some botanicals show promise in early studies (e.g., polyphenol-rich fruits, herbs), most have not been rigorously studied in human trials focusing on GLP-1
PCPs are a bedrock of healthcare, managing complex relationships with patients, learning each individuals unique medical history, and addressing comorbidities
injection of an anti-inflammatory drug (Diprospan, Flosteron) into the nerve compression zone
Figure 1 outlines some of these key investments